{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihlns7zciyeaod2kd6qqtb6udyosoqpb5bhlxajnpsdfioowze4ha",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnkl356qoco2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidu34472dzkk35qo5cic545c4wpoddoamrn4kotdjmnhrkylkipva"
    },
    "mimeType": "image/jpeg",
    "size": 525886
  },
  "path": "/news/2026-06-qa-expert-discusses-cannabis.html",
  "publishedAt": "2026-06-05T11:40:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "On April 26, the United States reclassified cannabis from a Schedule I controlled substance, which lacks any medical benefits, to a Schedule III controlled substance, which has accepted medical uses and lower potential for misuse than a Schedule I substance.",
  "title": "Q&A: Expert discusses risks of cannabis use"
}